Variables | Results | 3-year RFS Rate | P | |
---|---|---|---|---|
Age (median, months) | 46.5 (26,71.5) | |||
≥54 months (n, %) | YES | 37(66) | 63.9% | 0.007 |
No | 19(34) | 25% | ||
PRETEXT (n, %) | 0.089 | |||
I | 0 | 0 | ||
II | 26(46) | 65.4% | ||
III | 26(46) | 38.5% | ||
IV | 4(8) | 25% | ||
SIOPEL risk stratification (n, %) | 0.239 | |||
SR | 27(48) | 59.9% | ||
HR | 29(52) | 40.1% | ||
Tumor size (median, cm2) | 100.84 (69.76,142.31) | |||
Initial serum AFP (median, ng/ml) | 31,125 (5434,74,250) | |||
Non-recurrent (n) | 28 | |||
Recurrent (n) | 28 | |||
Site of tumour recurrence (n, %) | Local | 21(75) | ||
Lung metastasis | 7(25) | |||
Prognoses (n, %) | Survive | 46(82) | ||
Death | 7(13) | |||
Lost to follow up | 3(5) | |||
follow-up time (median, months) | 44 |